Welcome to the CURE blog.

/Blog/

CURE welcomes new member IMI Precision Engineering

The life science division of IMI Precision Engineering designs and manufactures OEM fluidic systems for life science and medical instruments. They provide turnkey solutions by integrating a wide array of gas and fluid handling components into compact, fully integrated and tested subassemblies for analytical, diagnostic, biotechnology, and medical device manufacturers. more

By |November 14th, 2017|News|0 Comments

Yancopoulos, Regeneron exec, talks to Washington

Regeneron’s George Yancopoulos is worried about the lack of investment in the NIH. He says Washington needs to remember the basics. more

By |November 14th, 2017|News|0 Comments

FDA clears antimicrobial tests re Melinta’s Baxdela

The FDA has cleared three antimicrobial susceptibility tests that will be available to guide physicians towards the appropriate usage of Baxdela™ (delafloxacin). Baxdela, available from Melinta Therapeutics in both intravenous and oral forms, is an FDA-approved fluoroquinolone indicated in adults for the treatment of acute bacterial skin and skin structure infections ... more Separately, Melinta announced the successful completion of its merger with Cempra ... more

By |November 14th, 2017|News|0 Comments

ReNetX receives $7M re spinal cord treatment

The Wings for Life foundation has made a significant commitment to ReNetX Bio, a New Haven based biotech startup that is advancing a cutting-edge therapy for chronic spinal cord injury to clinical trial. “Wings for Life has been an incredible partner,” says ReNetX CEO Erika R. Smith. “They have given us the means to accelerate launch for a full clinical trial that can provide us with the necessary data to advance these first-in-class therapeutics for patients suffering from chronic spinal cord injury.” more

By |November 14th, 2017|News|0 Comments

Medtronic reports progress on Intellis, TMVR

Medtronic’s Intellis platform grabbed a CE mark for peripheral nerve and spinal cord stimulation. With the nod, the device is now cleared to treat chronic, intractable pain of the trunk, posterior trunk and limbs ... more Separately, Medtronic has posted a look at data on the first 50 patients treated with its transcatheter mitral valve replacement (TMVR) system. The navigation of the early test follows shortly after Medtronic treated the first patient in the pivotal trial it hopes will establish it as a player in the nascent TMVR market. ... more

By |November 8th, 2017|News|0 Comments

Connecticut Innovations seeks investment associate

Connecticut Innovations is seeking an experienced bioscience investment associate. The associate will be focused on sourcing opportunities, business development, investment processes, and portfolio management. more

By |November 8th, 2017|News|0 Comments

Quercus wins funding for herpes simplex drug

Quercus Molecular Design, a UConn spinout, has won Phase I STTR funding from the National Institutes of Health to develop treatments for Herpes Simplex Virus. The one-year grant focuses on the development of multi-targeting inhibitors that block two or more essential proteins used in reproduction of the virus. more

By |November 8th, 2017|News|0 Comments

Arvinas reports progress on prostate cancer drug

Arvinas has announced the selection of its first candidate for clinical development as a novel treatment for metastatic castration-resistant prostate cancer (mCRPC). ARV-110 is an orally bioavailable small molecule PROTAC (PROteolysis TArgeting Chimera) designed to target and induce the degradation of the androgen receptor (AR) protein, which plays a prominent role in the development of mCRPC. more

By |November 8th, 2017|News|0 Comments

Melinta announces post merger leadership team

Melinta Therapeutics has announced the executive leadership team for the combined Melinta and Cempra business, which will keep the name Melinta Therapeutics upon the closing of the merger. more

By |November 8th, 2017|News|0 Comments

Entrepreneur Rothberg reimagines ultrasounds

Jonathan Rothberg, who helped ignite a revolution in DNA sequencing is setting his sights on a new disruption: reimagining the ultrasound scans that are a standard way for doctors to take pictures of what is going on inside the human body. more

By |November 8th, 2017|News|0 Comments